H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census population 474,069. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Raleigh clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Raleigh storefront.
Growth Factor Therapy for Tissue Repair in Raleigh, NC for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 19.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JM-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Adult obesity in Raleigh is 30.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 19.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JM / Palmetto GBA, sibling states SC, VA, WV. N.C. Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 9.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 9.1% of adults — 2.9 points below the U.S. 12% figure. Obesity is 30.9%; arthritis is 19.8%. That is place-level BRFSS modeling, not a clinic census and not a Raleigh trial.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Raleigh as local reviews.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
No. Palmetto GBA writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Ask for the IFU, the lot-traceability packet, and the Palmetto GBA article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Raleigh fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Raleigh, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Raleigh is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Raleigh — 2.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Raleigh. Useful for joint-program math; still needs a diagnosis and privileging.
No Raleigh storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.